A 62-year-old woman from Mumbai with a 15-year history of type 2 diabetes mellitus and hyperlipidemia (LDL 180 mg/dL) undergoes carotid ultrasound for stroke risk assessment. The scan reveals multiple atherosclerotic plaques in the carotid bifurcation with intimal-medial thickness (IMT) of 2.2 mm. Histopathological examination of a biopsy specimen shows extensive smooth muscle cell proliferation in the media, accumulation of extracellular lipid within the intima, and a well-organized fibrous cap. Which stage of atherosclerotic plaque development does this pathology represent?

Explanation

## Stages of Atherosclerotic Plaque Development **Key Point:** The histopathological findings—smooth muscle cell proliferation in the media, extracellular lipid in the intima, and a well-organized fibrous cap—define an **intermediate lesion** transitioning toward a fibroatheroma, not an advanced lipid-rich or complicated plaque. ### Classification of Atherosclerotic Lesions (AHA Classification) | Stage | Pathological Features | Clinical Significance | |-------|----------------------|----------------------| | **Type I (Fatty Streak)** | Macrophage foam cells in intima only; no SMC proliferation | Reversible; no hemodynamic obstruction | | **Type II (Intermediate)** | Smooth muscle cells in media; extracellular lipid in intima; fibrous cap forming | Transitional stage; progressive | | **Type III (Fibroatheroma)** | Well-formed fibrous cap; lipid core present but organized; SMC-rich | Stable; may cause hemodynamic obstruction | | **Type IV (Advanced Fibroatheroma)** | Large lipid-rich necrotic core; thin fibrous cap; macrophage infiltration | Vulnerable to rupture; risk of ACS | | **Type V (Complicated)** | Thrombosis, calcification, hemorrhage, plaque rupture | Acute coronary events | ### Why This Case Represents an Intermediate Lesion 1. **Smooth muscle cell proliferation in the media** — indicates the plaque is transitioning from fatty streak to a more complex lesion 2. **Extracellular lipid accumulation** — lipid is present but not yet organized into a large necrotic core 3. **Well-organized fibrous cap** — indicates the plaque is still stable and not vulnerable 4. **Elevated IMT (2.2 mm)** — confirms structural thickening consistent with intermediate-to-advanced disease **Clinical Pearl:** Intermediate lesions are the target of aggressive lipid-lowering therapy. Statins and ezetimibe can stabilize and potentially regress these lesions before they progress to lipid-rich fibroatheromas. **High-Yield:** The **transition from Type II to Type III** occurs over months to years in patients with uncontrolled dyslipidemia and diabetes. This patient's LDL of 180 mg/dL and diabetes accelerate this progression. **Mnemonic: SMC-FLIP** — **S**mooth **M**uscle **C**ells proliferate, **F**ibrous cap forms, **L**ipid accumulates extracellularly, **I**ntimal thickening occurs, **P**rogressively toward fibroatheroma. ### Distinguishing from Advanced Fibroatheroma Advanced fibroatheromas have: - A **lipid-rich necrotic core** (acellular, disorganized lipid) - **Thin fibrous cap** with macrophage infiltration - **Loss of SMC organization** This patient's **well-organized fibrous cap and SMC proliferation** rule out advanced disease.